A breakthrough has been made in the development of hepatitis E vaccine, an original biological medicine in China

Business News Agency August 31st News: “The newly developed hepatitis E vaccine is safe and effective, and it can be quickly listed after waiting for the approval of the drug regulatory department.” Yesterday, the person in charge of the Biotechnology and New Pharmaceutical Industry Promotion Center of the Beijing Science and Technology Commission disclosed that this marked China has reached world leading level in the development of hepatitis E vaccines.

Hepatitis E is one of the major viral hepatitis and there are no vaccines at home and abroad. It is estimated that one third of the world’s population has been infected with the hepatitis E virus. China is a highly endemic area of ​​hepatitis E, and the incidence has continued to rise in recent years. Recently, the Hepatitis E vaccine, jointly developed by the National Institute for the Diagnosis of Infectious Diseases and the Engineering Research Center for Vaccines, has achieved a major breakthrough and is expected to be available soon. Hepatitis E vaccine developed in China has so far obtained four domestic and international authorized invention patents, and it is one of the rare and highly original biological drugs in China.